User profiles for "author:Vinit B Mahajan"

Vinit B. Mahajan

Professor of Ophthalmology, Stanford University
Verified email at stanford.edu
Cited by 9548

[HTML][HTML] Viral delivery systems for CRISPR

CL Xu, MZC Ruan, VB Mahajan, SH Tsang - Viruses, 2019 - mdpi.com
The frontiers of precision medicine have been revolutionized by the development of
Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR)/Cas9 as an editing …

[HTML][HTML] Retinal and choroidal angiogenesis: a review of new targets

T Cabral, LGM Mello, LH Lima, J Polido… - International journal of …, 2017 - Springer
Retinal and choroidal neovascularization are a major cause of significant visual impairment,
worldwide. Understanding the various factors involved in the accompanying …

[HTML][HTML] Gene therapy and genome surgery in the retina

JE DiCarlo, VB Mahajan… - The Journal of clinical …, 2018 - Am Soc Clin Investig
Precision medicine seeks to treat disease with molecular specificity. Advances in genome
sequence analysis, gene delivery, and genome surgery have allowed clinician-scientists to …

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label …

S Russell, J Bennett, JA Wellman, DC Chung, ZF Yu… - The Lancet, 2017 - thelancet.com
Background Phase 1 studies have shown potential benefit of gene replacement in RPE65-
mediated inherited retinal dystrophy. This phase 3 study assessed the efficacy and safety of …

[HTML][HTML] Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes

JK White, AK Gerdin, NA Karp, E Ryder, M Buljan… - Cell, 2013 - cell.com
Mutations in whole organisms are powerful ways of interrogating gene function in a realistic
context. We describe a program, the Sanger Institute Mouse Genetics Project, that provides …

Unexpected mutations after CRISPR–Cas9 editing in vivo

KA Schaefer, WH Wu, DF Colgan, SH Tsang… - Nature …, 2017 - nature.com
CRISPR–Cas9 editing shows promise for correcting disease-causing mutations. For
example, in a recent study we used CRISPR-Cas9 for sight restoration in blind rd1 mice by …

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab

B Bakall, JC Folk, HC Boldt, EH Sohn, EM Stone… - American journal of …, 2013 - Elsevier
PURPOSE: To evaluate the outcome of intravitreal injection of aflibercept in cases with
exudative age-related macular degeneration,(AMD) resistant to injections of bevacizumab or …

Automated early detection of diabetic retinopathy

MD Abràmoff, JM Reinhardt, SR Russell, JC Folk… - Ophthalmology, 2010 - Elsevier
PURPOSE: To compare the performance of automated diabetic retinopathy (DR) detection,
using the algorithm that won the 2009 Retinopathy Online Challenge Competition in 2009 …

[HTML][HTML] Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells

AG Bassuk, A Zheng, Y Li, SH Tsang, VB Mahajan - Scientific reports, 2016 - nature.com
Induced pluripotent stem cells (iPSCs) generated from patient fibroblasts could potentially
be used as a source of autologous cells for transplantation in retinal disease. Patient …

Opposing T cell responses in experimental autoimmune encephalomyelitis

N Saligrama, F Zhao, MJ Sikora, WS Serratelli… - Nature, 2019 - nature.com
Experimental autoimmune encephalomyelitis is a model for multiple sclerosis. Here we
show that induction generates successive waves of clonally expanded CD4+, CD8+ and γδ+ …